Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer-Reference-Cited by-同舟云学术

Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer

Published:2013-09-03 Issue:3 Volume:14 Page:241-247
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Yao S,Sucheston L E,Zhao H,Barlow W E,Zirpoli G,Liu S,Moore H C F,Thomas Budd G,Hershman D L,Davis W,Ciupak G L,Stewart J A,Isaacs C,Hobday T J,Salim M,Hortobagyi G N,Gralow J R,Livingston R B,Albain K S,Hayes D F,Ambrosone C B

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/tpj201332.pdf

Reference27 articles.

1. Hassett MJ, O'Malley AJ, Pakes JR, Newhouse JP, Earle CC . Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst 2006; 98: 1108–1117.

2. Shapiro CL, Recht A . Side effects of adjuvant treatment of breast cancer. N Engl J Med 2001; 344: 1997–2008.

3. Choi JY, Nowell SA, Blanco JG, Ambrosone CB . The role of genetic variability in drug metabolism pathways in breast cancer prognosis. Pharmacogenomics 2006; 7: 613–624.

4. Yao S, Maghsoudlou D, Ambrosone CB . Breast cancer pharmacogenetics in the era of personalized medicine. Curr Breast Cancer Rep 2012; 4: 271–281.

5. Sladek NE, Kollander R, Sreerama L, Kiang DT . Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens. Cancer Chemother Pharmacol 2002; 49: 309–321.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of ALDH1A1 and NQO1 gene polymorphisms on the response and toxicity of chemotherapy in Bangladeshi breast cancer patients;Cancer Chemotherapy and Pharmacology;2024-07-16

2. Prognostic and Predictive Significance of mRNA Expression of ABC-transporter Genes in Patients with Non-small Cell Lung Cancer;Drug development & registration;2022-11-27

3. Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy;Cancers;2022-11-04

4. Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect;Clinical Pharmacokinetics;2022-09-30

5. Lack of association of CYP2B6 pharmacogenetics with cyclophosphamide toxicity in patients with cancer;Supportive Care in Cancer;2022-05-24